These medtech companies care a lot about research

  • These medtech companies care a lot about research

    They manufacture stents for the treatment of glaucoma, tumor treatment drapes, coin-sized CGMs and more. Find out which medical technology companies spend the most on research as a percentage of revenue. The list comes from our annual Big 100 report, which looks at the world’s 100 largest medical device companies and ranks them by revenue. (Check out our full Big 100 report… […]

  • Traco Power launches new AC/DC power supplies

    Traco Power (Baar, Switzerland) has announced its latest high-efficiency miniaturized AC/DC power supplies: the TPP 180 series for the medical and industrial sector and the TPI 180 series for industry. The power supplies measure just 2 x 3 x 1.24 inches in the open frame version – with global safety approvals for medical or industrial markets. They are available in 16 standard models with a… […]

  • NIH launches $9.8 million neuromodulation competition

    The National Institutes of Health (NIH) today announced the launch of the first phase of their Neuromod Prize competition. The Neuromod Prize, a $9.8 million competition, aims to accelerate the development of neuromodulation therapies. The NIH seeks scientists, engineers, and clinicians to submit novel concepts and clinical development plans to demonstrate solutions for stimulating the peripheral nervous system… […]

  • Junkosha increases production of PTFE liners and FEP-based heat-shrink tubing

    Junkosha today announced plans to double production capacity to address shortages of PTFE liners and FEP-based heat shrinks for catheter manufacturers. According to the Japanese maker of sophisticated fluoropolymer application technologies, catheter OEMs and contract manufacturers are stressed by shortages in the global supply of vital components. “We believe that… […]

  • Ahead of G7 launch, Dexcom CEO predicts ‘more activity than ever’ in 2022

    With a major product approval and launch in sight, Dexcom is gearing up for a big year in 2022. Throughout 2021, Dexcom (NSDQ: DXCM) has taken several steps forward. The company touted its next-generation G7 Continuous Glucose Monitor (CGM) and announced a major regulatory nod and partnership for real-time application programming interfaces (APIs), to name a few. only a few. As the new year begins, expectations for the… […]

  • Former Zimmer Biomet executive has a new job

    Carrie Nichol, the former chief accounting officer of Zimmer Biomet (NYSE:ZBH), has a new job outside of the medtech industry. Nichol, who also served as vice president, controller and chief accountant at Zimmer Biomet, is now vice president and controller at Cargill, based in Minnetonka, Minnesota. His departure was among many notable moves by medtech executives… […]

  • According to employees, Intuitive, Boston Scientific, J&J and Medtronic are among the best places to work in 2022

    Intuitive Surgical, Boston Scientific, Johnson & Johnson and Medtronic were recently named by Glassdoor as the best places to work in 2022 based on employee reviews. Each year, Glassdoor uses feedback employees have shared on the website over the past 12 months to compile a list of the best places to work for the next… […]

  • Medtronic’s M&A strategy explained by CFO Karen Parkhill

    When Medtronic CFO and Executive Vice President Karen Parkhill reflects on the medical device maker’s performance during the COVID-19 pandemic, she recalls a key decision that upset investors, but hurt its long-term results. “When I first joined Medtronic, it was shortly after the Covidien merger and we had incurred a lot of debt… […]

  • Loftware acquires Prisym ID

    Loftware announced the acquisition of Prisym ID, a provider of content management solutions and regulated labels. Prisym ID is focused on clinical trials, medical devices and pharmaceutical labeling, with the acquisition aimed at expanding Loftware’s enterprise labeling solutions offerings for the medical device and pharmaceutical industries while enhancing the platform -Loftware’s end-to-end cloud labeling form with… […]

  • BD, Pfizer, Wellcome want to improve hospital antimicrobial practices

    BD (NYSE:BDX) announced yesterday that it will work with Pfizer (NYSE:PFE) and Wellcome to advance antimicrobial stewardship practices. The collaboration builds on ongoing efforts to advance the role of diagnostics in addressing the challenge of antimicrobial resistance (AMR), according to a press release. Companies will review existing diagnostic practices to highlight benefits and shortcomings… […]

  • iRhythm CEO Considers Costs On Path To Profitability

    Fresh off the positive news about reimbursement for his Zio remote external electrocardiogram monitoring device, the CEO of iRhythm Technologies (NSDQ:IRTC) doesn’t just have revenue on his mind. iRhythm President and CEO Quentin Blackford — the former Dexcom COO who replaced Mike Coyle in September — said his company will have to control costs as it… […]

  • Comments are closed.